Collins R. Jones
- Molecular Biology
- Pharmacology top 2%
- Nutrition and Dietetics top 10%
- Biochemistry top 5%
- Oncology
- Co-authors
- Ronald A. LubetStanley I. RapoportMichael ChangRaymond W. NimsKonstantin H. DragnevJane M. BellBhalchandra A. DiwanMark Steven Miller
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Eicosanoids and Hypertension Pharmacology (12 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Collins R. Jones
22 papers receiving 561 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 201
- Pharmacology 190
- Nutrition and Dietetics 133
- Biochemistry 116
- Oncology 86
Countries citing papers authored by Collins R. Jones
This map shows the geographic impact of Collins R. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collins R. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collins R. Jones more than expected).
Fields of papers citing papers by Collins R. Jones
This network shows the impact of papers produced by Collins R. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collins R. Jones. The network helps show where Collins R. Jones may publish in the future.
Co-authorship network of co-authors of Collins R. Jones
This figure shows the co-authorship network connecting the top 25 collaborators of Collins R. Jones. A scholar is included among the top collaborators of Collins R. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collins R. Jones. Collins R. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 70 | |
| 2 | 5 | |
| 3 | 33 | |
| 4 | In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. | 30 |
| 5 | 6 | |
| 6 | 57 | |
| 7 | 9 | |
| 8 | 19 | |
| 9 | 8 | |
| 10 | 10 | |
| 11 | 17 | |
| 12 | 9 | |
| 13 | 21 | |
| 14 | 87 | |
| 15 | 13 | |
| 16 | 27 | |
| 17 | The use of drug metabolizing enzymes as a marker of exposure to low doses of polychlorinated biphenyls pcbs in rodents laboratory and field studies | 1 |
| 18 | 38 | |
| 19 | Characterization of dose-response relationships in the induction of liver drug metabolizing enzymes in F344 rats by graded doses of Aroclor 1254 | 1 |
| 20 | 17 |
About Collins R. Jones
Collins R. Jones is a scholar working on Biochemistry, Pharmacology and Clinical Biochemistry, having authored 23 papers that have together received 587 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Eicosanoids and Hypertension Pharmacology (12 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (190 citations), Biochemistry (116 citations) and Nutrition and Dietetics (133 citations). Collins R. Jones has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Ronald A. Lubet, Stanley I. Rapoport, Michael Chang, Raymond W. Nims, Konstantin H. Dragnev, Jane M. Bell, Bhalchandra A. Diwan, Mark Steven Miller, Jerrold M. Ward and Paul E. Thomas. Their work appears in journals such as Brain Research, The FASEB Journal and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.